Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Modified Thoracoabdominal Nerve Block(M-TAPA) in Total Laparoscopic Hysterectomies

  • Read more about Modified Thoracoabdominal Nerve Block(M-TAPA) in Total Laparoscopic Hysterectomies

Moderate-vigorous Intermittent Physical Activity (M-VILPA) in Stroke

  • Read more about Moderate-vigorous Intermittent Physical Activity (M-VILPA) in Stroke

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

  • Read more about COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

  • Read more about A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Study to Investigate the Efficacy of Abrocitinib in Adult Participants with Severe Fatigue from Post COVID Condition/Long COVID

  • Read more about Study to Investigate the Efficacy of Abrocitinib in Adult Participants with Severe Fatigue from Post COVID Condition/Long COVID

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

  • Read more about A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction

  • Read more about Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction

tVNS in Long COVID-19

  • Read more about tVNS in Long COVID-19

A Study to Investigate the Immunogenicity of mRNA COVID-19 Variant-containing Vaccine Formulations in Adults to Prevent COVID-19

  • Read more about A Study to Investigate the Immunogenicity of mRNA COVID-19 Variant-containing Vaccine Formulations in Adults to Prevent COVID-19

Faron Pharmaceuticals Ltd

By jpalfreyman on Wed, 09/04/2024 - 09:28
  • Read more about Faron Pharmaceuticals Ltd

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Current page 46
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA